Noble Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 23-06-2024
- Paid Up Capital ₹ 5.36 Cr
as on 23-06-2024
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.85 Cr
as on 23-06-2024
- Satisfied Charges ₹ 8.54 Cr
as on 23-06-2024
- Revenue 158.57%
(FY 2021)
- Profit 2059.92%
(FY 2021)
- Ebitda 95.19%
(FY 2021)
- Net Worth 109.42%
(FY 2021)
- Total Assets 13.20%
(FY 2021)
About Noble Pharmacare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.36 Cr.
The company currently has active open charges totaling ₹1.85 Cr. The company has closed loans amounting to ₹8.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satyabrata Garabadu, Subrat Garabadu, Pradipta Garabadu, and One other member serve as directors at the Company.
- CIN/LLPIN
U24236OR1989PLC002307
- Company No.
002307
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jul 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Noble Pharmacare Limited. offer?
Noble Pharmacare Limited. offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Noble Pharmacare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subrat Garabadu  | Managing Director | 10-Jul-1989 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyabrata Garabadu | Director | 10-Jul-1989 | Current |
| Pradipta Garabadu | Director | 01-Nov-2020 | Current |
| Debabrata Garabadu | Director | 10-Jul-1989 | Current |
Financial Performance of Noble Pharmacare.
Noble Pharmacare Limited., for the financial year ended 2021, experienced significant growth in revenue, with a 158.57% increase. The company also saw a substantial improvement in profitability, with a 2059.92% increase in profit. The company's net worth Soared by an impressive increase of 109.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noble Pharmacare?
In 2021, Noble Pharmacare had a promoter holding of 78.88% and a public holding of 21.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 18 Aug 2023 | ₹1.25 Cr | Open |
Sidbi Creation Date: 18 Aug 2023 | ₹5.00 M | Open |
Others Creation Date: 31 Mar 2023 | ₹1.00 M | Open |
How Many Employees Work at Noble Pharmacare?
Unlock and access historical data on people associated with Noble Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
